Company: INCR
Filing Date: 2025-09-19
Form Type: 6-K
Source: 0001493152-25-014152
Chunk: 2

Company: Intercure Ltd.
Filing Date: 2025-09-19
Form: 6-K
Chunk 2
---
 the acquisition. These forward-looking statements and their implications are based on the current expectations of the management of InterCure only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, InterCure undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting InterCure is contained under the heading “Risk Factors” in InterCure’s annual report on Form 20-F for the year ended December 31, 2024 filed with the Securities and Exchange Commission, or SEC, which is available on the SEC’s website, www.sec.gov, and in subsequent filings made by InterCure with the SEC.

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Date: September 19, 2025 | INTERCURE LTD.          
 /s/ Amos                
 Cohen                   |
|:-------------------------|:------------------------|
|                          | Amos Cohen              |
|                          | Chief Financial Officer |